Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anita Beggiato is active.

Publication


Featured researches published by Anita Beggiato.


Biological Psychiatry | 2015

Neuroanatomical Diversity of Corpus Callosum and Brain Volume in Autism: Meta-analysis, Analysis of the Autism Brain Imaging Data Exchange Project, and Simulation.

Aline Lefebvre; Anita Beggiato; Thomas Bourgeron; Roberto Toro

BACKGROUND Patients with autism have been often reported to have a smaller corpus callosum (CC) than control subjects. METHODS We conducted a meta-analysis of the literature, analyzed the CC in 694 subjects of the Autism Brain Imaging Data Exchange project, and performed computer simulations to study the effect of different analysis strategies. RESULTS Our meta-analysis suggested a group difference in CC size; however, the studies were heavily underpowered (20% power to detect Cohens d = .3). In contrast, we did not observe significant differences in the Autism Brain Imaging Data Exchange cohort, despite having achieved 99% power. However, we observed that CC scaled nonlinearly with brain volume (BV): large brains had a proportionally smaller CC. Our simulations showed that because of this nonlinearity, CC normalization could not control for eventual BV differences, but using BV as a covariate in a linear model would. We also observed a weaker correlation of IQ and BV in cases compared with control subjects. Our simulations showed that matching populations by IQ could then induce artifactual BV differences. CONCLUSIONS The lack of statistical power in the previous literature prevents us from establishing the reality of the claims of a smaller CC in autism, and our own analyses did not find any. However, the nonlinear relationship between CC and BV and the different correlation between BV and IQ in cases and control subjects may induce artifactual differences. Overall, our results highlight the necessity for open data sharing to provide a more solid ground for the discovery of neuroimaging biomarkers within the context of the wide human neuroanatomical diversity.


Scientific Data | 2017

Enhancing studies of the connectome in autism using the autism brain imaging data exchange II

Adriana Di Martino; David O'Connor; Bosi Chen; Kaat Alaerts; Jeffrey S. Anderson; Michal Assaf; Joshua H. Balsters; Leslie C. Baxter; Anita Beggiato; Sylvie Bernaerts; Laura M. E. Blanken; Susan Y. Bookheimer; B. Blair Braden; Lisa Byrge; F. Xavier Castellanos; Mirella Dapretto; Richard Delorme; Damien A. Fair; Inna Fishman; Jacqueline Fitzgerald; Louise Gallagher; R. Joanne Jao Keehn; Daniel P. Kennedy; Janet E. Lainhart; Beatriz Luna; Stewart H. Mostofsky; Ralph Axel Müller; Mary Beth Nebel; Joel T. Nigg; Kirsten O'Hearn

The second iteration of the Autism Brain Imaging Data Exchange (ABIDE II) aims to enhance the scope of brain connectomics research in Autism Spectrum Disorder (ASD). Consistent with the initial ABIDE effort (ABIDE I), that released 1112 datasets in 2012, this new multisite open-data resource is an aggregate of resting state functional magnetic resonance imaging (MRI) and corresponding structural MRI and phenotypic datasets. ABIDE II includes datasets from an additional 487 individuals with ASD and 557 controls previously collected across 16 international institutions. The combination of ABIDE I and ABIDE II provides investigators with 2156 unique cross-sectional datasets allowing selection of samples for discovery and/or replication. This sample size can also facilitate the identification of neurobiological subgroups, as well as preliminary examinations of sex differences in ASD. Additionally, ABIDE II includes a range of psychiatric variables to inform our understanding of the neural correlates of co-occurring psychopathology; 284 diffusion imaging datasets are also included. It is anticipated that these enhancements will contribute to unraveling key sources of ASD heterogeneity.


Autism Research | 2017

Gender differences in autism spectrum disorders: Divergence among specific core symptoms

Anita Beggiato; Hugo Peyre; Anna Maruani; Isabelle Scheid; Maria Råstam; Frédérique Amsellem; Carina Gillberg; Marion Leboyer; Thomas Bourgeron; Christopher Gillberg; Richard Delorme

Community‐based studies have consistently shown a sex ratio heavily skewed towards males in autism spectrum disorders (ASD). The factors underlying this predominance of males are largely unknown, but the way girls score on standardized categorical diagnostic tools might account for the underrecognition of ASD in girls. Despite the existence of different norms for boys and girls with ASD on several major screening tests, the algorithm of the Autism Diagnosis Interview‐Revised (ADI‐R) has not been reformulated. The aim of our study was to investigate which ADI‐R items discriminate between males and females, and to evaluate their weighting in the final diagnosis of autism. We then conducted discriminant analysis (DA) on a sample of 594 probands including 129 females with ASD, recruited by the Paris Autism Research International Sibpair (PARIS) Study. A replication analysis was run on an independent sample of 1716 probands including 338 females with ASD, recruited through the Autism Genetics Resource Exchange (AGRE) program. Entering the raw scores for all ADI‐R items as independent variables, the DA correctly classified 78.9% of males and 72.9% of females (P < 0.001) in the PARIS cohort, and 72.2% of males and 68.3% of females (P < 0.0001) in the AGRE cohort. Among the items extracted by the stepwise DA, four belonged to the ADI‐R algorithm used for the final diagnosis of ASD. In conclusion, several items of the ADI‐R that are taken into account in the diagnosis of autism significantly differentiates between males and females. The potential gender bias thus induced may participate in the underestimation of the prevalence of ASD in females. Autism Res 2016,.


Molecular Psychiatry | 2017

CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders

Oriane Mercati; Guillaume Huguet; Anne Danckaert; Gwénaëlle André-Leroux; Anna Maruani; Marco Bellinzoni; Thomas Rolland; Laura Gouder; Alexandre Mathieu; Julien Buratti; Fréderique Amsellem; Marion Benabou; J Van-Gils; Anita Beggiato; Marina Konyukh; J-P Bourgeois; M J Gazzellone; Ryan K. C. Yuen; Susan Walker; Marc Delepine; Anne Boland; Béatrice Regnault; Martine François; T Van Den Abbeele; Anne-Laure Mosca-Boidron; Laurence Faivre; Yasushi Shimoda; Kazutada Watanabe; Dominique Bonneau; Maria Råstam

Contactin genes CNTN5 and CNTN6 code for neuronal cell adhesion molecules that promote neurite outgrowth in sensory-motor neuronal pathways. Mutations of CNTN5 and CNTN6 have previously been reported in individuals with autism spectrum disorders (ASDs), but very little is known on their prevalence and clinical impact. In this study, we identified CNTN5 and CNTN6 deleterious variants in individuals with ASD. Among the carriers, a girl with ASD and attention-deficit/hyperactivity disorder was carrying five copies of CNTN5. For CNTN6, both deletions (6/1534 ASD vs 1/8936 controls; P=0.00006) and private coding sequence variants (18/501 ASD vs 535/33480 controls; P=0.0005) were enriched in individuals with ASD. Among the rare CNTN6 variants, two deletions were transmitted by fathers diagnosed with ASD, one stop mutation CNTN6W923X was transmitted by a mother to her two sons with ASD and one variant CNTN6P770L was found de novo in a boy with ASD. Clinical investigations of the patients carrying CNTN5 or CNTN6 variants showed that they were hypersensitive to sounds (a condition called hyperacusis) and displayed changes in wave latency within the auditory pathway. These results reinforce the hypothesis of abnormal neuronal connectivity in the pathophysiology of ASD and shed new light on the genes that increase risk for abnormal sensory perception in ASD.


American Journal of Medical Genetics Part A | 2015

11q24.2-25 micro-rearrangements in autism spectrum disorders: Relation to brain structures.

Anna Maruani; Guillaume Huguet; Anita Beggiato; Monique Elmaleh; Roberto Toro; Claire S. Leblond; Alexandre Mathieu; Frédérique Amsellem; Nathalie Lemière; Alain Verloes; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron; Richard Delorme

Jacobsen syndrome (JS) is characterized by intellectual disability and higher risk for autism spectrum disorders (ASD). All patients with JS are carriers of contiguous de novo deletions of 11q24.2‐25, but the causative genes remain unknown. Within the critical interval, we hypothesized that haploinsufficiency of the neuronal cell adhesion molecule Neurotrimin (NTM) might increase the risk for ASD and could affect brain structure volumes. We searched for deleterious mutations affecting NTM in 1256 ASD patients and 1287 controls, using SNP arrays, and by direct sequencing of 250 ASD patients and 180 controls. We compared our results to those obtained from independent cohorts of ASD patients and controls. We identified two patients with Copy Number Variants (CNV) encompassing NTM, one with a large de novo deletion, and a clinical phenotype of JS (including macrocephaly), and a second with a paternally inherited duplication, not consistent with JS. Interestingly, no similar CNVs were observed in controls. We did not observe enrichment for deleterious NTM mutations in our cohort. We then explored if the macrocephaly in the patient with JS was associated with a homogeneous increase of brain structures volumes using automatic segmentation. Compared to subjects without NTM micro‐rearrangements (n=188), the patient had an increased volume of the sub‐cortical structures but a decrease of the occipital gray matter. Finally our explorations could not incriminate NTM as a susceptibility gene for ASD, but provides new information on the impact of the 11q24.2‐25 deletion on brain anatomy.


bioRxiv | 2014

Neuroanatomical diversity of corpus callosum and brain volume in the Autism Brain Imaging Data Exchange (Abide) project

Aline Lefebvre; Anita Beggiato; Thomas Bourgeron; Roberto Toro

The corpus callosum – the main pathway for long-distance inter-hemispheric integration in the human brain – has been frequently reported to be smaller among autistic patients compared with non-autistic controls. We conducted a meta-analysis of the literature which suggested a statistically significant difference. However, the studies included were heavily underpowered: on average only 20% power to detect differences of 0.3 standard deviations, which makes it difficult to establish the reality of such a difference. We therefore studied the size of the corpus callosum among 694 subjects (328 patients, 366 controls) from the Abide cohort. Despite having achieved 99% power to detect statistically significant differences of 0.3 standard deviations, we did not observe any. To better understand the neuroanatomical diversity of the corpus callosum, and the possible reasons for the previous findings, we analysed the relationship between its size, the size of the brain, intracranial volume and intelligence scores. The corpus callosum appeared to scale non-linearly with brain size, with large brains having a proportionally smaller corpus callosum. Additionally, intelligence scores correlated with brain volume among controls but the correlation was significantly weaker among patients. We used simulations to determine to which extent these two effects could lead to artefactual differences in corpus callosum size within populations. We observed that, were there a difference in brain volume between cases and controls, normalising corpus callosum size by brain volume would not eliminate the brain volume effect, but adding brain volume as a covariate in a linear model would. Finally, we observed that because of the weaker correlation of intelligence scores and brain volume among patients, matching populations by intelligence scores could result in a bias towards including more patients with large brain volumes, inducing an artificial difference. Overall, our results highlight the necessity for open data sharing efforts such as Abide to provide a more solid ground for the discovery of neuroimaging biomarkers, within the context of the wide human neuroanatomical diversity.


BMC Medical Genetics | 2013

Heterozygous FA2H mutations in autism spectrum disorders.

Isabelle Scheid; Anna Maruani; Guillaume Huguet; Claire S. Leblond; Gudrun Nygren; Henrik Anckarsäter; Anita Beggiato; Maria Råstam; Frédederique Amsellem; I. Carina Gillberg; Monique Elmaleh; Marion Leboyer; Christopher Gillberg; Catalina Betancur; Mary Coleman; Hiroko Hama; Edwin H. Cook; Thomas Bourgeron; Richard Delorme

BackgroundWidespread abnormalities in white matter development are frequently reported in cases of autism spectrum disorders (ASD) and could be involved in the disconnectivity suggested in these disorders. Homozygous mutations in the gene coding for fatty-acid 2-hydroxylase (FA2H), an enzyme involved in myelin synthesis, are associated with complex leukodystrophies, but little is known about the functional impact of heterozygous FA2H mutations. We hypothesized that rare deleterious heterozygous mutations of FA2H might constitute risk factors for ASD.MethodsWe searched deleterious mutations affecting FA2H, by genotyping 1256 independent patients with ASD genotyped using Genome Wide SNP arrays, and also by sequencing in independent set of 186 subjects with ASD and 353 controls. We then explored the impact of the identified mutations by measuring FA2H enzymatic activity and expression, in transfected COS7 cells.ResultsOne heterozygous deletion within 16q22.3-q23.1 including FA2H was observed in two siblings who share symptoms of autism and severe cognitive impairment, axial T2-FLAIR weighted MRI posterior periventricular white matter lesions. Also, two rare non-synonymous mutations (R113W and R113Q) were reported. Although predictive models suggested that R113W should be a deleterious, we did not find that FA2H activity was affected by expression of the R113W mutation in cultured COS cells.ConclusionsWhile our results do not support a major role for FA2H coding variants in ASD, a screening of other genes related to myelin synthesis would allow us to better understand the role of non-neuronal elements in ASD susceptibility.


Current Developmental Disorders Reports | 2014

Anatomical and Functional Brain Imaging in Childhood ADHD: Update 2013

Marco Angriman; Anita Beggiato; Samuele Cortese

Neuroimaging studies of attention-deficit/hyperactivity disorder (ADHD) are continuously adding to our knowledge on the neurobiology of this condition. Here, we update previous narrative and systematic reviews on the neuroimaging of ADHD, focusing on studies published in 2013. In order to comprehensively retrieve all the published studies, we searched a broad range of electronic databases (PubMed, Ovid PsychInfo, Ovide Medline, Web of Science, and EMBASE). We critically overview anatomical magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) studies, as well as functional MRI and resting state MRI studies. We also included studies aimed at elucidating the mechanism of action of ADHD drugs. We conclude that the combination of multimodal neuroimaging techniques has the potential not only to increase our understanding of structural disruptions in neuronal circuits associated with functional deficits in children with ADHD, but also to provide objective data that may assist the clinician in the day-to-day practice.


bioRxiv | 2017

Cerebellar volume in autism: Meta-analysis and analysis of the ABIDE cohort

Nicolas Traut; Anita Beggiato; Thomas Bourgeron; Richard Delorme; Laure Rondi-Reig; Anne-Lise Paradis; Roberto Toro

Cerebellar volume abnormalities have been often suggested as a possible endophenotype for autism spectrum disorder (ASD). We aimed at objectifying this possible alteration by performing a systematic meta-analysis of the literature, and an analysis of the Autism Brain Imaging Data Exchange (ABIDE) cohort. Our meta-analysis sought to determine a combined effect size of ASD diagnosis on different measures of the cerebellar anatomy, as well as the effect of possible factors of variability across studies. We then analysed the cerebellar volume of 328 patients and 353 controls from the ABIDE project. The meta-analysis of the literature suggested a weak but significant association between ASD diagnosis and increased cerebellar volume (p=0.049, uncorrected), but the analysis of ABIDE did not show any relationship. The studies in the literature were generally underpowered, however, the number of statistically significant findings was larger than expected. Although we could not provide a conclusive explanation for this excess of significant findings, our analyses would suggest publication bias as a possible reason. Finally, age, sex and IQ were important sources of cerebellar volume variability, however, independent of autism diagnosis.


bioRxiv | 2018

Reproducible functional connectivity alterations are associated with autism spectrum disorder

Stefan Holiga; Joerg F. Hipp; Christopher H. Chatham; Pilar Garces; Will Spooren; Xavier Logier D'Ardhuy; Alessandro Bertolino; Céline Bouquet; Jan K. Buitelaar; Carsten Bours; Annika Rausch; Marianne Oldehinkel; Manuel Bouvard; Anouck Amestoy; Mireille Caralp; Sonia Gueguen; Myriam Ly-Le Moal; Josselin Houenou; Christian F. Beckmann; Eva Loth; Declan Murphy; Tony Charman; Julian Tillmann; Charles Laidi; Richard Delorme; Anita Beggiato; Alexandru Gaman; Isabelle Scheid; Marion Leboyer; Marc-Antoine d'Albis

Despite the high clinical burden little is known about pathophysiology underlying autism spectrum disorder (ASD). Recent resting state functional magnetic resonance imaging (rs-fMRI) studies have found atypical synchronization of brain activity in ASD. However, no consensus has been reached on the nature and clinical relevance of these alterations. Here we address these questions in the most comprehensive, large-scale effort to date comprising evaluation of four large ASD cohorts. We followed a strict exploration and replication procedure to identify core rs-fMRI functional connectivity (degree centrality) alterations associated with ASD as compared to typically developing (TD) controls (ASD: N=841, TD: N=984). We then tested for associations of these imaging phenotypes with clinical and demographic factors such as age, sex, medication status and clinical symptom severity. We find reproducible patterns of ASD-associated functional hyper-and hypo-connectivity with hypo-connectivity being primarily restricted to sensory-motor regions and hyperconnectivity hubs being predominately located in prefrontal and parietal cortices. We establish shifts in between-network connectivity from outside to within the identified regions as a key driver of these abnormalities. The magnitude of these alterations is linked to core ASD symptoms related to communication and social interaction and is not affected by age, sex or medication status. The identified brain functional alterations provide a reproducible pathophysiological phenotype underlying the diagnosis of ASD reconciling previous divergent findings. The large effect sizes in standardized cohorts and the link to clinical symptoms emphasize the importance of the identified imaging alterations as potential treatment and stratification biomarkers for ASD.

Collaboration


Dive into the Anita Beggiato's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge